SlideShare a Scribd company logo
1 of 1
Results
Insulin ThT
• Figures 3 and 4 show the fibrillation results for
human and bovine insulin respectively.
Materials and Methods
Peptide Synthesis
• Sequence of human fragment: Asn-Glu-Leu-Gln-
Tyr-Leu-Ser-Cys-Ile-Ser-Thr
• Sequence of bovine fragment: Asn-Glu-Leu-Gln-
Tyr-Leu-Ser-Cys-Val-Ser-Ala
• Sequence for tailored peptide: Leu-Leu-Leu-Leu-
Leu-Lys-Lys-Lys-Lys-Lys
• Each peptide has a lysine tail in an attempt to
increase its solubility
Introduction
Diseases such as Alzheimer’s and Parkinson’s are
linked to amyloid deposits, which are insoluble
protein aggregates. Some polypeptides that form
amyloid fibrils are insulin and (Lys)n-b-(Ile)m. We
found that the fibrillation of diblock peptides is
around 72 hours from Naik (2012) at pH 4. The
diblock peptide used here can be shown in Figure 1.
We also found that bovine and human insulin have
different fibrillation kinetics in spite of the fact of
being almost identical molecules; they differ in four
amino acids (Figure 2). We hypothesized that
shorter fragments of insulin variants that include the
region which lacks homology should have the same
differences in the kinetics of fibrillation. Thioflavin-T
Fluorescent Spectroscopy (ThT) was used to explore
the differences.
Material and Methods Continued
Experiment of Design
Fibrillation of Bovine and Human Insulin Fragments and Tailored Peptides
Al-Lozi, A., Snyder, A., and Dr. Forciniti
Chemical and Biochemical Engineering
Missouri University of Science and Technology
Conclusion
• Fragments of bovine and human insulin seem
to be forming amyloid fibrils
• It is not clear if there is a kinetic difference
between the two fragments
• ThT results suggest that the bovine fragment
has a higher propensity to form fibrils
• The pH’s used in this research were different
from Naik, therefore, no conclusions can be
made on the fibrillation of diblock peptides
Results Continued
Thank you Dr. Daniel Forciniti for your assistance and OURE at Missouri S&T for funding
Materials and Methods
Fibrillation
• 17 solutions containing 10mg and 20mg of
each insulin fragment (human and bovine) in 1
mL of 2mM sodium phosphate buffer, pH 2.5
and pH 7
• 24 solutions containing 10mg and 20mg of the
tailored peptide in 1mL of 2mM sodium
phosphate buffer, pH 2.5 and pH 7
• The samples were then incubated at 60°C (with
and without agitation) and at 40°C (with and
without agitation)
• Two samples of bovine insulin were started on
March 1, 2015 to test the conditions for the
run that should produce the most fibrils and
the run that should produce the least amount
of fibrils
• The next set of samples were started March 20,
2015 for both the 17 insulin samples and 24
tailored peptide samples
ThT (Thioflavin-T Fluorescence Spectroscopy)
• A Stock solution was prepared by adding 4 mg
of Thioflavin T to 5 mL of phosphate buffer
• 20µL were added to every 1mL sample. More
was added every two weeks due to the
degradation of the ThT working solution
• The excitation wavelength was fixed at 480nm
with extra wavelength set at 490nm and
500nm
• The samples were tested once every week in
triplicate
From the graphs, much information can be
viewed:
• There is a visible difference between the
bovine and human fibrillation as the bovine
insulin aggregates faster than the human
insulin
• There is also a difference between the
temperatures and pH levels where the higher
temperature and lower pH was more likely to
produce more fibrils than the lower
temperature and higher pH
• As the incubation time increases, the
concentration of fibrils increase as well
Tailored Peptide ThT
• Fibrils were expected to form within the first
week for the diblock peptides. However, this
was not the case. At first, it appeared that the
fibrils exhibited slow kinetics under the
conditions of the experiment. The samples
were left to incubate for a total of four weeks,
and no sign of fibrils were shown under ThT
fluorescence.
Ala
ValAla
Leu Leu Leu Leu Leu Lys Lys Lys Lys Lys
Diblock Peptide
Figure 1: Amino acid sequence of tailored peptide of diblock
Figure 2: Amino acid sequence of human insulin and the difference of Bovine insulin
0 200 400 600 800 1000 1200 1400 1600
Week 1
Week 2
RFU @ 480
Time(weeks)
Run 12 Run 8 Run 6 Run 5 Run 3 Run 13 Run 11 Run 10 Run 9 Run 7 Run 4 Run 2 Run 1
Figure 3: Human insulin data for two weeks after initial incubation
Figure 4: Bovine insulin data from initial incubation
Run pH Temp. (°C) Agitation Concentration (mg/ mL)
1 2.5 40 off 10
2 2.5 40 off 20
3 2.5 40 on 10
4 2.5 40 on 20
5 2.5 60 off 10
6 2.5 60 off 20
7 2.5 60 on 10
8 2.5 60 on 20
9 7 40 off 20
10 7 40 on 10
11 7 60 off 10
12 7 60 on 20
13 7 40 off 10
Table 1: Experimental Design for Human and Bovine insulin fragments and tailored peptide incubation.
0
1000
2000
3000
4000
5000
6000
7000
Week 0 Week 1 Week 2
RFU@480
Time (weeks)
Run 1 Run 2 Run 12 Run 11 1 2 11 12

More Related Content

Viewers also liked

NiccoleChicca_Resume2015
NiccoleChicca_Resume2015NiccoleChicca_Resume2015
NiccoleChicca_Resume2015Niccole Chicca
 
Atividade contabilidade
Atividade  contabilidadeAtividade  contabilidade
Atividade contabilidadenando gomes
 
Vertigo opening scene analysis
Vertigo opening scene analysisVertigo opening scene analysis
Vertigo opening scene analysisOctave Gascoin
 
Caren magill UnResume & Professional Story
Caren magill UnResume & Professional StoryCaren magill UnResume & Professional Story
Caren magill UnResume & Professional StoryCaren Magill-Myers
 
EXAMEN ADAPTADO PARA ALUMNADO TDAH
EXAMEN ADAPTADO PARA ALUMNADO TDAHEXAMEN ADAPTADO PARA ALUMNADO TDAH
EXAMEN ADAPTADO PARA ALUMNADO TDAHpintshei
 
Situación de Aprendizaje
Situación de AprendizajeSituación de Aprendizaje
Situación de AprendizajeLubana Balanzar
 
Eskulanal 1. zikloa Manualidades 1.Ciclo
Eskulanal 1. zikloa Manualidades 1.CicloEskulanal 1. zikloa Manualidades 1.Ciclo
Eskulanal 1. zikloa Manualidades 1.CicloItzalai Alberdi
 

Viewers also liked (8)

NiccoleChicca_Resume2015
NiccoleChicca_Resume2015NiccoleChicca_Resume2015
NiccoleChicca_Resume2015
 
Atividade contabilidade
Atividade  contabilidadeAtividade  contabilidade
Atividade contabilidade
 
Vertigo opening scene analysis
Vertigo opening scene analysisVertigo opening scene analysis
Vertigo opening scene analysis
 
kevin_resumenew
kevin_resumenewkevin_resumenew
kevin_resumenew
 
Caren magill UnResume & Professional Story
Caren magill UnResume & Professional StoryCaren magill UnResume & Professional Story
Caren magill UnResume & Professional Story
 
EXAMEN ADAPTADO PARA ALUMNADO TDAH
EXAMEN ADAPTADO PARA ALUMNADO TDAHEXAMEN ADAPTADO PARA ALUMNADO TDAH
EXAMEN ADAPTADO PARA ALUMNADO TDAH
 
Situación de Aprendizaje
Situación de AprendizajeSituación de Aprendizaje
Situación de Aprendizaje
 
Eskulanal 1. zikloa Manualidades 1.Ciclo
Eskulanal 1. zikloa Manualidades 1.CicloEskulanal 1. zikloa Manualidades 1.Ciclo
Eskulanal 1. zikloa Manualidades 1.Ciclo
 

Similar to Fibrillation of Bovine and Human Insulin Fragments and Tailored Peptides

LIPID CHEMISTRY Question Bank vnd.ms-powerpoint&rendition=1-4.ppt
LIPID CHEMISTRY Question Bank vnd.ms-powerpoint&rendition=1-4.pptLIPID CHEMISTRY Question Bank vnd.ms-powerpoint&rendition=1-4.ppt
LIPID CHEMISTRY Question Bank vnd.ms-powerpoint&rendition=1-4.pptLogesh Kannan
 
formulation and evaluation of insulin loaded nanoparticles.pptx
formulation and evaluation of insulin loaded nanoparticles.pptxformulation and evaluation of insulin loaded nanoparticles.pptx
formulation and evaluation of insulin loaded nanoparticles.pptxTenzinPema20
 
Insulin and its Analogues.pptx
Insulin and its Analogues.pptxInsulin and its Analogues.pptx
Insulin and its Analogues.pptxMuneebJawad
 
myo-Inositol as a Biomarker for Type II Diabetes.pptx
myo-Inositol as a Biomarker for Type II Diabetes.pptxmyo-Inositol as a Biomarker for Type II Diabetes.pptx
myo-Inositol as a Biomarker for Type II Diabetes.pptxNilberto Nascimento
 
Liposome based protien and peptide delivery
Liposome based protien and peptide deliveryLiposome based protien and peptide delivery
Liposome based protien and peptide deliverySayeda Salma S.A.
 
Shariq bioassay
Shariq bioassayShariq bioassay
Shariq bioassaysharimycin
 
Sperm sexing toll like receptor
Sperm sexing toll like receptorSperm sexing toll like receptor
Sperm sexing toll like receptorMohammadKiani23
 
Bioassy of insulin according to Indian pharmacopoeia
Bioassy of insulin according to Indian pharmacopoeiaBioassy of insulin according to Indian pharmacopoeia
Bioassy of insulin according to Indian pharmacopoeiaSONALPANDE5
 
Chemistry of lipids phospholipids
Chemistry of lipids phospholipidsChemistry of lipids phospholipids
Chemistry of lipids phospholipidsRavi Kiran
 
Models for testing_activity_of_diuretics
Models for testing_activity_of_diureticsModels for testing_activity_of_diuretics
Models for testing_activity_of_diureticsMOHANLAL CHOUDHARY
 
Bioassay of insulin
Bioassay of insulinBioassay of insulin
Bioassay of insulinKomal Sathe
 
Final Poster SS 2015 Kemmerling, O'Rourke, Pearsall
Final Poster SS 2015 Kemmerling, O'Rourke, PearsallFinal Poster SS 2015 Kemmerling, O'Rourke, Pearsall
Final Poster SS 2015 Kemmerling, O'Rourke, PearsallHannah Pearsall
 
Ukicrs poster april 2016 (1)
Ukicrs  poster april 2016 (1)Ukicrs  poster april 2016 (1)
Ukicrs poster april 2016 (1)Mohammad Hussain
 

Similar to Fibrillation of Bovine and Human Insulin Fragments and Tailored Peptides (20)

USRTP Poster
USRTP PosterUSRTP Poster
USRTP Poster
 
LIPID CHEMISTRY Question Bank vnd.ms-powerpoint&rendition=1-4.ppt
LIPID CHEMISTRY Question Bank vnd.ms-powerpoint&rendition=1-4.pptLIPID CHEMISTRY Question Bank vnd.ms-powerpoint&rendition=1-4.ppt
LIPID CHEMISTRY Question Bank vnd.ms-powerpoint&rendition=1-4.ppt
 
formulation and evaluation of insulin loaded nanoparticles.pptx
formulation and evaluation of insulin loaded nanoparticles.pptxformulation and evaluation of insulin loaded nanoparticles.pptx
formulation and evaluation of insulin loaded nanoparticles.pptx
 
Pharmacy students and their parents and general health
Pharmacy students and their parents and general healthPharmacy students and their parents and general health
Pharmacy students and their parents and general health
 
Insulin and its Analogues.pptx
Insulin and its Analogues.pptxInsulin and its Analogues.pptx
Insulin and its Analogues.pptx
 
myo-Inositol as a Biomarker for Type II Diabetes.pptx
myo-Inositol as a Biomarker for Type II Diabetes.pptxmyo-Inositol as a Biomarker for Type II Diabetes.pptx
myo-Inositol as a Biomarker for Type II Diabetes.pptx
 
Pou5 f1 copy
Pou5 f1   copyPou5 f1   copy
Pou5 f1 copy
 
project work
project workproject work
project work
 
Liposome based protien and peptide delivery
Liposome based protien and peptide deliveryLiposome based protien and peptide delivery
Liposome based protien and peptide delivery
 
Nutrients
NutrientsNutrients
Nutrients
 
BONE HEALTH.pptx
BONE HEALTH.pptxBONE HEALTH.pptx
BONE HEALTH.pptx
 
Shariq bioassay
Shariq bioassayShariq bioassay
Shariq bioassay
 
Sperm sexing toll like receptor
Sperm sexing toll like receptorSperm sexing toll like receptor
Sperm sexing toll like receptor
 
Bioassy of insulin according to Indian pharmacopoeia
Bioassy of insulin according to Indian pharmacopoeiaBioassy of insulin according to Indian pharmacopoeia
Bioassy of insulin according to Indian pharmacopoeia
 
Chemistry of lipids phospholipids
Chemistry of lipids phospholipidsChemistry of lipids phospholipids
Chemistry of lipids phospholipids
 
Models for testing_activity_of_diuretics
Models for testing_activity_of_diureticsModels for testing_activity_of_diuretics
Models for testing_activity_of_diuretics
 
Bioassay of insulin
Bioassay of insulinBioassay of insulin
Bioassay of insulin
 
amniotic fluid analysis
amniotic fluid analysisamniotic fluid analysis
amniotic fluid analysis
 
Final Poster SS 2015 Kemmerling, O'Rourke, Pearsall
Final Poster SS 2015 Kemmerling, O'Rourke, PearsallFinal Poster SS 2015 Kemmerling, O'Rourke, Pearsall
Final Poster SS 2015 Kemmerling, O'Rourke, Pearsall
 
Ukicrs poster april 2016 (1)
Ukicrs  poster april 2016 (1)Ukicrs  poster april 2016 (1)
Ukicrs poster april 2016 (1)
 

Fibrillation of Bovine and Human Insulin Fragments and Tailored Peptides

  • 1. Results Insulin ThT • Figures 3 and 4 show the fibrillation results for human and bovine insulin respectively. Materials and Methods Peptide Synthesis • Sequence of human fragment: Asn-Glu-Leu-Gln- Tyr-Leu-Ser-Cys-Ile-Ser-Thr • Sequence of bovine fragment: Asn-Glu-Leu-Gln- Tyr-Leu-Ser-Cys-Val-Ser-Ala • Sequence for tailored peptide: Leu-Leu-Leu-Leu- Leu-Lys-Lys-Lys-Lys-Lys • Each peptide has a lysine tail in an attempt to increase its solubility Introduction Diseases such as Alzheimer’s and Parkinson’s are linked to amyloid deposits, which are insoluble protein aggregates. Some polypeptides that form amyloid fibrils are insulin and (Lys)n-b-(Ile)m. We found that the fibrillation of diblock peptides is around 72 hours from Naik (2012) at pH 4. The diblock peptide used here can be shown in Figure 1. We also found that bovine and human insulin have different fibrillation kinetics in spite of the fact of being almost identical molecules; they differ in four amino acids (Figure 2). We hypothesized that shorter fragments of insulin variants that include the region which lacks homology should have the same differences in the kinetics of fibrillation. Thioflavin-T Fluorescent Spectroscopy (ThT) was used to explore the differences. Material and Methods Continued Experiment of Design Fibrillation of Bovine and Human Insulin Fragments and Tailored Peptides Al-Lozi, A., Snyder, A., and Dr. Forciniti Chemical and Biochemical Engineering Missouri University of Science and Technology Conclusion • Fragments of bovine and human insulin seem to be forming amyloid fibrils • It is not clear if there is a kinetic difference between the two fragments • ThT results suggest that the bovine fragment has a higher propensity to form fibrils • The pH’s used in this research were different from Naik, therefore, no conclusions can be made on the fibrillation of diblock peptides Results Continued Thank you Dr. Daniel Forciniti for your assistance and OURE at Missouri S&T for funding Materials and Methods Fibrillation • 17 solutions containing 10mg and 20mg of each insulin fragment (human and bovine) in 1 mL of 2mM sodium phosphate buffer, pH 2.5 and pH 7 • 24 solutions containing 10mg and 20mg of the tailored peptide in 1mL of 2mM sodium phosphate buffer, pH 2.5 and pH 7 • The samples were then incubated at 60°C (with and without agitation) and at 40°C (with and without agitation) • Two samples of bovine insulin were started on March 1, 2015 to test the conditions for the run that should produce the most fibrils and the run that should produce the least amount of fibrils • The next set of samples were started March 20, 2015 for both the 17 insulin samples and 24 tailored peptide samples ThT (Thioflavin-T Fluorescence Spectroscopy) • A Stock solution was prepared by adding 4 mg of Thioflavin T to 5 mL of phosphate buffer • 20µL were added to every 1mL sample. More was added every two weeks due to the degradation of the ThT working solution • The excitation wavelength was fixed at 480nm with extra wavelength set at 490nm and 500nm • The samples were tested once every week in triplicate From the graphs, much information can be viewed: • There is a visible difference between the bovine and human fibrillation as the bovine insulin aggregates faster than the human insulin • There is also a difference between the temperatures and pH levels where the higher temperature and lower pH was more likely to produce more fibrils than the lower temperature and higher pH • As the incubation time increases, the concentration of fibrils increase as well Tailored Peptide ThT • Fibrils were expected to form within the first week for the diblock peptides. However, this was not the case. At first, it appeared that the fibrils exhibited slow kinetics under the conditions of the experiment. The samples were left to incubate for a total of four weeks, and no sign of fibrils were shown under ThT fluorescence. Ala ValAla Leu Leu Leu Leu Leu Lys Lys Lys Lys Lys Diblock Peptide Figure 1: Amino acid sequence of tailored peptide of diblock Figure 2: Amino acid sequence of human insulin and the difference of Bovine insulin 0 200 400 600 800 1000 1200 1400 1600 Week 1 Week 2 RFU @ 480 Time(weeks) Run 12 Run 8 Run 6 Run 5 Run 3 Run 13 Run 11 Run 10 Run 9 Run 7 Run 4 Run 2 Run 1 Figure 3: Human insulin data for two weeks after initial incubation Figure 4: Bovine insulin data from initial incubation Run pH Temp. (°C) Agitation Concentration (mg/ mL) 1 2.5 40 off 10 2 2.5 40 off 20 3 2.5 40 on 10 4 2.5 40 on 20 5 2.5 60 off 10 6 2.5 60 off 20 7 2.5 60 on 10 8 2.5 60 on 20 9 7 40 off 20 10 7 40 on 10 11 7 60 off 10 12 7 60 on 20 13 7 40 off 10 Table 1: Experimental Design for Human and Bovine insulin fragments and tailored peptide incubation. 0 1000 2000 3000 4000 5000 6000 7000 Week 0 Week 1 Week 2 RFU@480 Time (weeks) Run 1 Run 2 Run 12 Run 11 1 2 11 12